| Model Number |
QC-4-12-3D |
| Medical Device Problem Code |
Detachment of Device or Device Component (2907)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/19/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Medtronic received information that an axium coil prematurely detached.After the spring coil was deployed, it was adjusted without being detached.When retrieved a part of the spring coil, it was found that the spring coil was detached.The part of the spring coil that had been detached at this time was located in the intermediate catheter, so sab was used to enter the intermediate catheter.The doctor opened the stent to press the spring coil and withdrew the whole part.The pushwire was not bent or broken.There was no friction or difficulty during delivery.The physician did not reposition the coil or rotate the delivery pusher during the procedure.Continuous flush was not administered during the procedure.The devices were prepared according to the instructions for use (ifu).The patient was being treated for an unruptured, saccular aneurysm in the posterior communicating segment of the left brain.The m ax diameter was 5.2mm and the neck diameter was 3.5mm.Patient blood flow and vessel tortuosity was normal.No patient injury was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Additional information received reported the cause of the premature detachment was not determined.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|